GlaxoSmithKline Financial Overview
GlaxoSmithKline's market cap is currently $98.47B. The company's EPS TTM is $1.457; its P/E ratio is 13.73; and it has a dividend yield of 3.42%. GlaxoSmithKline is scheduled to report earnings on October 29, 2025, and the estimated EPS forecast is $0.63. See an overview of income statement, balance sheet, and cash flow financials.
